KRAS and colonic neoplasm: The results we present here suggested that oncogenic mutant KRAS increases TNT-mediated cross-talk between colon cancer cells and that these cells harness these TNTs to further disperse KRAS molecules to other wild-type KRAS colon cancer cells.